This release brings a major update to the user interface (UI) in CAT4. The UI updates include:

• New Graph types
• Consistent colour scheme throughout all graphs
• Traffic light scheme applied where relevant
• Simplified logon and improved user interface

Other changes:

• Update to requirements to .Net 4.5.2 from .Net 4.0
• Added lipid modifying drugs:
  • Alirocumab and Evolocumab
  • Added diabetes drugs:
    • Ertugliflozin (Steglataro)
    • Ertugliflozin/sitagliptin (Steglujan)   
    • Ertugliflozin/metformin (Brand name: Segluromet)
  • Added heart medication Abisart
  • Redesign for GoShare functionality
  • Changed CV Event Risk report to provide more meaningful categories
  • Removed Pap Smear report as it is now replaced by cervical screening
  • Added new category ‘opted out/no longer required’ to cervical screening report (MD/BP only)
  • Some minor fixes for PIP QI reports
  • Performance enhancements and numerous minor fixes